首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Radiosynthesis and 'click' conjugation of ethynyl-4-[F-18]fluorobenzene an improved [F-18]synthon for indirect radiolabeling
【24h】

Radiosynthesis and 'click' conjugation of ethynyl-4-[F-18]fluorobenzene an improved [F-18]synthon for indirect radiolabeling

机译:乙炔基-4- [F-18]氟苯的放射合成和“点击”偶联是一种改进的[F-18]合成子,用于间接放射性标记

获取原文
获取原文并翻译 | 示例
           

摘要

Reproducible methods for [F-18]radiolabeling of biological vectors are essential for the development of new [F-18]radiopharmaceuticals. Molecules such as carbohydrates, peptides and proteins are challenging substrates that often require multi-step indirect radiolabeling methods. With the goal of developing more robust, time saving, and less expensive procedures for indirect [F-18]radiolabeling of such molecules, our group has synthesized ethynyl-4-[F-18]fluorobenzene ([F-18]2, [F-18]EYFB) in a single step (14 +/- 2% non-decay corrected radiochemical yield (ndc RCY)) from a readily synthesized, shelf stable, inexpensive precursor. The alkyne-functionalized synthon [F-18]2 was then conjugated to two azido-functionalized vector molecules via CuAAC reactions. The first proof of principle' conjugation of [F-18]2 to 1-azido-1-deoxy--d-glucopyranoside (3) gave the desired radiolabeled product [F-18]4 in excellent radiochemical yield (76 +/- 4% ndc RCY (11% overall)). As a second example, the conjugation of [F-18]2 to matrix-metalloproteinase inhibitor (5), which has potential in tumor imaging, gave the radiolabeled product [F-18]6 in very good radiochemical yield (56 +/- 12% ndc RCY (8% overall)). Total preparation time for [F-18]4 and [F-18]6 including [F-18]F- drying, two-step reaction (nucleophilic substitution and CuAAC conjugation), two HPLC purifications, and two solid phase extractions did not exceed 70min. The radiochemical purity of synthon [F-18]2 and the conjugated products, [F-18]4 and [F-18]6, were all greater than 98%. The specific activities of [F-18]2 and [F-18]6 were low, 5.97 and 0.17MBqnmol(-1), respectively.
机译:生物载体[F-18]放射性标记的可再现方法对于开发新的[F-18]放射性药物至关重要。诸如碳水化合物,肽和蛋白质之类的分子是具有挑战性的底物,通常需要多步间接放射性标记方法。为了开发出更健壮,省时和便宜的方法来间接进行此类分子的[F-18]放射性标记,我们小组合成了乙炔基-4- [F-18]氟苯([F-18] 2,[ F-18] EYFB),一步一步即可得到(14 +/- 2%非衰变校正的放射化学收率(ndc RCY)),是由易于合成,货架稳定,廉价的前体制成的。然后通过CuAAC反应将炔基官能化的合成子[F-18] 2与两个叠氮基官能化的载体分子缀合。 [F-18] 2与1-叠氮基-1-脱氧-d-吡喃葡萄糖苷结合的原理上的第一个证据(3)以优异的放射化学收率(76 +/-)得到了所需的放射性标记产物[F-18] 4 ndc RCY为4%(总体为11%)。作为第二个例子,[F-18] 2与基质金属蛋白酶抑制剂(5)的结合在肿瘤成像中具有潜力,使放射标记的产物[F-18] 6的放射化学产率非常高(56 +/- ndc RCY为12%(整体8%)。 [F-18] 4和[F-18] 6的总制备时间(包括[F-18] F-干燥,两步反应(亲核取代和CuAAC偶联),两次HPLC纯化和两次固相萃取)没有超过70分钟。合成子[F-18] 2和结合产物[F-18] 4和[F-18] 6的放射化学纯度均大于98%。 [F-18] 2和[F-18] 6的比活分别较低,分别为5.97和0.17MBqnmol(-1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号